S4: E1 Building a Global AI Framework for Clinical Trials
Artificial intelligence is reshaping every stage of drug development, but unlocking its full potential requires more than technology alone. In this episode, Clay Alspach (Executive Director, ACRO) Raja Shankar (VP of Machine Learning at IQVIA), and Andrew Mackinnon (SVP & Executive General Manager at Medable) come together to examine how policy, regulation, and global collaboration will shape the future of AI in clinical trials.From breaking down data silos to addressing regulatory uncertainty and enabling a “try first” mindset, the discussion highlights both the opportunities and the complexities ahead. With insights on patient impact, site experience, and the next wave of innovation, this episode offers a roadmap for advancing AI in a way that is both responsible and transformative.
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
Listen to This Episode
More from ACRO's Good Clinical Podcast
S4: E7 Advancing Sustainability Through Smarter Clinical Trial Design
S4: E6 Collaborating to Drive Global Progress in Clinical Research
S4: E5 Advancing Rare Disease Research Through AI Innovation and Patient Trust
S4: E4 Improving Site Feasibility Through Better Data Collaboration and Timing
Get summaries like this every morning.
Free AI-powered recaps of ACRO's Good Clinical Podcast and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.